- Home
- ASND vs QNT Comparison
ASND vs QNT Comparison
Compare ASND & QNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$259.21
N/A
Current Price
$75.80
Company Overview
Basic Information| Metric | ASND | QNT |
|---|---|---|
| Founded | 2006 | N/A |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 15.1B |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ASND | QNT |
|---|---|---|
| Price | $259.21 | $75.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $281.50 | N/A |
| AVG Volume (30 Days) | 671.6K | ★ 4.0M |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $96.35 | N/A |
| Revenue Next Year | $44.91 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $161.09 | $64.53 |
| 52 Week High | $271.89 | $81.48 |
Technical Indicators
Market Signals| Indicator | ASND | QNT |
|---|---|---|
| Relative Strength Index (RSI) | 68.16 | N/A |
| Support Level | $213.28 | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 11.32 | 0.00 |
| MACD | 4.80 | 0.00 |
| Stochastic Oscillator | 79.96 | 0.00 |
Price Performance
Historical Comparison ASND
QNT
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.